Cresco Labs Reports Third Quarter 2026 Financial Results
Key Highlights
- ➤Q3 revenue $173 million, up 5% year-over-year
- ➤Adjusted EBITDA $35 million, with a 20.2% margin
- ➤Operating cash flow $26 million; free cash flow $21 million
- ➤Net loss $15 million versus $22 million a year earlier
- ➤Cash, equivalents, and restricted cash totaled $76 million; debt reached $454 million
Expert Statements
Charlie Bachtell, CEO of Cresco Labs
“Q3 delivered revenue of $173 million, up 5% year-over-year, and $26 million in operating cash flow, converting over 60% of Adjusted EBITDA into free cash flow,”
Charlie Bachtell, CEO of Cresco Labs
“The Cresco team executed this quarter as we closed an acquisition, improved cultivation, and ramped up a new state, all while keeping the base business running at a high level.”
Charlie Bachtell, CEO of Cresco Labs
“Last quarter we said we were doing everything within our control so that when federal regulations allow, we will be ready for our next chapter.”
Charlie Bachtell, CEO of Cresco Labs
“Last week our shareholders approved three special resolutions with over 94% support, simplifying our corporate structure and aligning Cresco with the U.S. investor base that will increasingly own this industry as it normalizes.”
Charlie Bachtell, CEO of Cresco Labs
“That said, we do not build our plan around reform timelines.”
Charlie Bachtell, CEO of Cresco Labs
“The business stands on its own, and Cresco will be ready to act when the next phase arrives.”
Delivers $173 Million in Revenue and $26 Million Operating Cash Flow
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the third quarter ended September 30, 2026. All financial information presented in this release is reported in accordance with U.S. GAAP and in U.S. dollars, unless otherwise indicated, and is available on the Company’s investor website, here .
Get started
Create a free account to read the full story.